HealthCore's research environment includes one of the largest longitudinal repositories of real-world health plan, practitioner and patient data existing in a single database in the United States.
These research environment assets, combined with HealthCore's experienced clinical and scientific staff, including epidemiologists, physicians, pharmacists, nurses, outcomes researchers, and biostatisticians, allow HealthCore to capture a more complete picture of the actual management of the patient--from the information gathered in the physician's office to their medical and pharmacy claims data--along with their physician's observations.
Among other initiatives, HealthCore is currently working with physicians on a two-year, multi-center prospective, observational study for patents with Type 2 diabetes on a specific therapy. The study is following outcomes and assessing clinical effectiveness in a real-world setting by integrating clinical practice and administrative claims level data.
The IRN(SM) will facilitate and shorten the life-cycle of prospective effectiveness research and comparative effectiveness research initiatives, such as those funded by the $1.1 billion grant program administered by the National Institutes of Health, Agency for Healthcare Research and Quality, and U.S. Department of Health and Human Services.
The IRN(SM) brings together physicians, hospital leaders, clinical researchers and pharmacists to identify clinical issues to study, provide clinical data for ongoing studies, respond to health surveys, and recruit and enroll patients in comparative effectiveness studies.
"Our immediate access to physicians will help facilitate real-world studies that can generate results quickly," said Dr. Louise Short, IRN(SM) medical director for HealthCore. "Ou
|SOURCE HealthCore, Inc.|
Copyright©2009 PR Newswire.
All rights reserved